Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy (Q38258842)

1 September 2017

1 reference

title

Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy (English)

1 reference

1 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303057%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Harry D Bear

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303057%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Masoud H Manjili

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303057%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

1 August 2014

1 reference

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303057%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303057%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303057%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

1779-1794

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303057%20AND%20SRC:MED&resulttype=core&format=json

Cancer immunoediting and "spontaneous" tumor regression

5 June 2020

cites work

1 reference

Occurrence of malignancy in immunodeficiency diseases. A literature review

21 January 2018

1 reference

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

21 January 2018

1 reference

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

21 January 2018

1 reference

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

21 January 2018

1 reference

Chimeric antigen receptor--modified T cells: clinical translation in stem cell transplantation and beyond

21 January 2018

1 reference

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study

21 January 2018

1 reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

21 January 2018

1 reference

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

21 January 2018

1 reference

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody

21 January 2018

1 reference

PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication

21 January 2018

1 reference

Do the terms innate and adaptive immunity create conceptual barriers?

21 January 2018

1 reference

Cooperativity of adaptive and innate immunity: implications for cancer therapy

21 January 2018

1 reference

Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses

21 January 2018

1 reference

The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment

21 January 2018

1 reference

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

21 January 2018

1 reference

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

21 January 2018

1 reference

Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

21 January 2018

1 reference

Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL

21 January 2018

1 reference

Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients

21 January 2018

1 reference

Targeting tumours with genetically enhanced T lymphocytes

21 January 2018

1 reference

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

21 January 2018

1 reference

Cell transfer immunotherapy for metastatic solid cancer--what clinicians need to know.

21 January 2018

1 reference

CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foe.

21 January 2018

1 reference

T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia.

21 January 2018

1 reference

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

21 January 2018

1 reference

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

21 January 2018

1 reference

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

21 January 2018

1 reference

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

21 January 2018

1 reference

Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia

21 January 2018

1 reference

Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.

21 January 2018

1 reference

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

21 January 2018

1 reference

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.

21 January 2018

1 reference

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

21 January 2018

1 reference

Inducible apoptosis as a safety switch for adoptive cell therapy

21 January 2018

1 reference

CD28 costimulation Impairs the efficacy of a redirected t-cell antitumor attack in the presence of regulatory t cells which can be overcome by preventing Lck activation

21 January 2018

1 reference

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

Transfer of specificity by murine alpha and beta T-cell receptor genes

21 January 2018

1 reference

High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes

21 January 2018

1 reference

Retroviral-mediated gene transfer in primary murine and human T-lymphocytes

21 January 2018

1 reference

Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors.

21 January 2018

1 reference

T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCR.

21 January 2018

1 reference

Comparison of lentiviral and sleeping beauty mediated αβ T cell receptor gene transfer

21 January 2018

1 reference

Challenges in T cell receptor gene therapy.

21 January 2018

1 reference

CD3 limits the efficacy of TCR gene therapy in vivo

21 January 2018

1 reference

Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

21 January 2018

1 reference

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells

21 January 2018

1 reference

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

21 January 2018

1 reference

Myeloid-derived suppressor cells: a double-edged sword?

21 January 2018

1 reference

Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells

21 January 2018

1 reference

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion.

21 January 2018

1 reference

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse.

21 January 2018

1 reference

Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.

21 January 2018

1 reference

IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.

21 January 2018

1 reference

NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo

21 January 2018

1 reference

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

21 January 2018

1 reference

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection

21 January 2018

1 reference

Natural killer cells trigger differentiation of monocytes into dendritic cells

21 January 2018

1 reference

Natural killer-dendritic cell cross-talk in cancer immunotherapy

21 January 2018

1 reference

Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients

21 January 2018

1 reference

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

21 January 2018

1 reference

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma

21 January 2018

1 reference

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure.

21 January 2018

1 reference

Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer

21 January 2018

1 reference

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

21 January 2018

1 reference

Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors

21 January 2018

1 reference

PKC-θ exists in an oxidized inactive form in naive human T cells.

21 January 2018

1 reference

Protein kinase C (PKC) alpha and PKC theta are the major PKC isotypes involved in TCR down-regulation

21 January 2018

1 reference

Three-dimensional segregation of supramolecular activation clusters in T cells

21 January 2018

1 reference

Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity

21 January 2018

1 reference

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

21 January 2018

1 reference

Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours?

21 January 2018

1 reference

IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo

21 January 2018

1 reference

Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2

21 January 2018

1 reference

IL-7 is critical for homeostatic proliferation and survival of naive T cells

21 January 2018

1 reference

Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells

21 January 2018

1 reference

IL-15 regulates homeostasis and terminal maturation of NKT cells

21 January 2018

1 reference

Cytokine control of memory T-cell development and survival

21 January 2018

1 reference

A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.

21 January 2018

1 reference

Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy

21 January 2018

1 reference

Interleukin 2 receptor gene expression in normal human T lymphocytes

21 January 2018

1 reference

Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

21 January 2018

1 reference

Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2

21 January 2018

1 reference

Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes

21 January 2018

1 reference

IL-2-dependent adaptive control of NK cell homeostasis

21 January 2018

1 reference

IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells

21 January 2018

1 reference

Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2.

21 January 2018

1 reference

IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo

21 January 2018

1 reference

A dynamic dual role of IL-2 signaling in the two-step differentiation process of adaptive regulatory T cells

21 January 2018

1 reference

IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells

21 January 2018

1 reference

Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function

21 January 2018

1 reference

Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity

21 January 2018

1 reference

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

21 January 2018

1 reference

Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

21 January 2018

1 reference

Fas and the art of lymphocyte maintenance

21 January 2018

1 reference

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

21 January 2018

1 reference

IL-7 promotes the transition of CD4 effectors to persistent memory cells

21 January 2018

1 reference

Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo

21 January 2018

1 reference

Innate-like effector differentiation of human invariant NKT cells driven by IL-7.

21 January 2018

1 reference

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

21 January 2018

1 reference

Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}

21 January 2018

1 reference

Distinct roles for IL-2 and IL-15 in the differentiation and survival of CD8+ effector and memory T cells.

21 January 2018

1 reference

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

21 January 2018

1 reference

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

21 January 2018

1 reference

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo

21 January 2018

1 reference

Different NK cell developmental events require different levels of IL-15 trans-presentation.

21 January 2018

1 reference

Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation.

21 January 2018

1 reference

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients.

21 January 2018

1 reference

A signature of immune function genes associated with recurrence-free survival in breast cancer patients

21 January 2018

1 reference

Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment

21 January 2018

1 reference

Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy

21 January 2018

1 reference

The immune score as a new possible approach for the classification of cancer

21 January 2018

1 reference

NKT cells direct monocytes into a DC differentiation pathway

21 January 2018

1 reference

Opposing Effects of PKCθ and WASp on Symmetry Breaking and Relocation of the Immunological Synapse

21 January 2018

1 reference

IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines

21 January 2018

1 reference

Interleukin-2 augments natural killer cell activity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.14.97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303057%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference